CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • 5 Things to Know if You Missed CICON24

    CICON24 wrapped up on September 11, 2024, at the Gaylord National Resort and Convention Center in National…
    September 13, 2024| Ajit Muley, PhD
  • Supercharging T Cells to Fight Cancer: A Revolutionary Discovery

    In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out…
    September 13, 2024| Ajit Muley, PhD
  • CICON24 Day 4 Recap: Pioneering Cellular Therapies and Cancer Vaccines Shape the Future of Cancer Treatment

    Led by inaugural CRI Lloyd J. Old STAR, Yvonne Chen, PhD, from UCLA, day four of CICON24…
    September 11, 2024| Ajit Muley, PhD
  • CICON24 Day 3 Recap: Advances in T Cell Tolerance, Metabolism, and the Microbiome in Cancer Immunotherapy

    Day three of CICON24 continued the momentum of the previous days with an impressive lineup of talks…
    September 10, 2024| Ajit Muley, PhD
  • CICON24 Day 2 Recap: Exploring Cancer Vaccines, Immune Health, and Future Therapies 

    NATIONAL HARBOR —Day two of CICON24 began with an impactful keynote by Cathy Wu, MD, from Dana…
    September 9, 2024| Ajit Muley, PhD
  • Introducing Dr. Alicia Zhou: A New Chapter in Leadership at the Cancer Research Institute

    The Cancer Research Institute (CRI) is excited to announce a transformative moment in its history with the…
    September 9, 2024| CRI Staff
  • CICON24 Day 1 Recap: Groundbreaking Research and Collaboration Driving the Future of Cancer Immunotherapy 

    NATIONAL HARBOR — CICON24 officially kicked off today at the Gaylord National Resort and Convention Center in…
    September 8, 2024| Ajit Muley, PhD
  • Prostate Cancer Awareness Month: Unlocking the Power of Immunotherapy to Combat a Common Men’s Cancer

    Prostate cancer is the second most common for men, only trailing skin cancer. Approximately 1.3 million men…
    September 6, 2024| Max Mallet
  • Blood Cancer Awareness Month: How Immunotherapy Fights Leukemia, Lymphoma, and Multiple Myeloma

    ‘Blood cancer’ is an all-encompassing term for cancers that impact millions of people globally every year. The…
    September 4, 2024| Max Mallet
Previous Page
1 … 3 4 5 6 7 … 91
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute